J0225 Injection, vutrisiran, 1 milligrams
Also known as: vutrisiran, Revozlyr
Vutrisiran injection 1 milligram, a small interfering ribonucleic acid (siRNA) for transthyretin amyloidosis.
In Plain Language
genetic disease gene therapy; hereditary amyloidosis treatment
Clinical Context
Intravenous siRNA targeting transthyretin messenger ribonucleic acid for hereditary transthyretin amyloidosis. Reduces transthyretin levels, slowing amyloid accumulation and disease progression.
RVU Information
CPT J0225 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J0225?
CPT J0225 (Injection, vutrisiran, 1 milligrams) is a J Codes (Drugs) code. Vutrisiran injection 1 milligram, a small interfering ribonucleic acid (siRNA) for transthyretin amyloidosis.
How is J0225 administered?
CPT J0225 is administered by a healthcare provider, typically via injection or infusion. Intravenous siRNA targeting transthyretin messenger ribonucleic acid for hereditary transthyretin amyloidosis. Reduces transthyretin levels, slowing amyloid accumulation and disease progression. It is used by Genetics, Neurology, Internal Medicine.
When is CPT J0225 used?
Intravenous siRNA targeting transthyretin messenger ribonucleic acid for hereditary transthyretin amyloidosis. Reduces transthyretin levels, slowing amyloid accumulation and disease progression.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.